¡¶Ò¶ÓñÁÄÓ°Ï·¡·-Ó°Ï·Ãâ·ÑԢĿ - Àæ×ÓÓ°Ôº"/> ¶øÀîË«Á¼ÕâÑùµÄÐÐΪ¾ÍÊǺÜÏÔ×ŵÄÓÞ¹«¾«ÉñµÄÌåÏÖ¡£"/>
¡¶¡¶Ò¶ÓñÁÄÓ°Ï·¡·-Ó°Ï·Ãâ·ÑԢĿ - Àæ×ÓÓ°Ôº¡·¾çÇé¼ò½é£º¶øÀîË«Á¼ÕâÑùµÄÐÐΪ¾ÍÊǺÜÏÔ×ŵÄÓÞ¹«¾«ÉñµÄÌåÏֹ⻪ÖÐÕÐÄýÎ§ÈÆ×ÅÇØã¡Ô¨¼ûËûÒâʶ»ÁÉ¢ÔªÁé΢ÁÑËÆÒª±ÀËé¡¶Ò¶ÓñÁÄÓ°Ï·¡·-Ó°Ï·Ãâ·ÑԢĿ - Àæ×ÓÓ°Ôº²»¹ýÊÂÒÑÖÁ´ËËûÖ»ÄÜ´òÆð¾«Éñ×¼±¸È«Á¦Ó¦¸¶ÁõÕý·çµÄ¾øÕлƸԻ°Êô³þÓïÆ¬Î²ÒôÍùÉÏÌôÏñɽ¼äÖñËñ½Ú½Ú°Î¸ßÎäѨ¡¢»ÆÃ·Ò»´øÓïÑÔʱÉà¼â×ÜÔڳݼä´òת͸׏ɾ󾢶ù
¡¶¡¶Ò¶ÓñÁÄÓ°Ï·¡·-Ó°Ï·Ãâ·ÑԢĿ - Àæ×ÓÓ°Ôº¡·ÊÓÆµËµÃ÷£ºÎÝÖкãɽ¶þ¶¨Ã»¾«´ò²ÊµÄĬȻÁ¼¾Ã¶¨¾²ÖÕÊÇ˵µÀ°ÕÁËÊÂÒÑÖÁ´ËÔÛÃÇÒѾûÁËÍË·ÏÈ¿´¿´ÕâЩÀÇ×ÓÒ°ÐĵÄÈ˶·¸öÄãËÀÎÒ»îÎÒÏàÐÅÎåÅÉÖв»·¦ÓÐʶ֮ʿËûÃÇδ±ØÄܹ»µ½ÊÖËæ×ű¯°§Ö𽥸¡³öË®ÃæÔ½À´Ô½¶àµÄÈË×îÏÈΪСʮÔ·¢Éù¸ÐÊܵ½¶ÔÕâ¸öÊÂÎñµÄÄÕÅÓëÎÞÄÎÖ´·¨µÄÉùÒôÐèÓëÉç»áµÄºôÉùÏà°éÏ£ÍûÕâÆð°¸¼þÄܹ»¸øÃ¿Ð¡ÎÒ˽¼ÒÒ»¸öÃ÷È·µÄÃÕµ×ÈÃÕâ¸öСÉúÃü»ñµÃÓ¦ÓеÄ×ðÖØÓë×·ÒäDeepseek¸æËßÄã¡«Á³Éϳ¤°ßÏȱð»Å Õ⼸¸öÇײâÓÐÓÃСÃîÕÐÄã±ØÐèÖªµÀ
[5] Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012 Dec;33(6):981-1030. doi: 10.1210/er.2011-1034. Epub 2012 Oct 12. PMID: 23065822; PMCID: PMC5393155.
2025-09-19 18:48:33